Pharmaceutical

Sanofi and AstraZeneca to supply additional RSV doses to US

The US government is set to receive an additional 230,000 doses of RSV injection Beyfortus from Sanofi and AstraZeneca in January 2024.

Dec 16, 2023 - 18:00
Sanofi and AstraZeneca to supply additional RSV doses to US
The US government is set to receive an additional 230,000 doses of RSV injection Beyfortus from Sanofi and AstraZeneca in January 2024.
Read the original article

Tags:

Previous Article

Biovac receives IFC loan for vaccine manufacturing in Africa

Next Article

Reneo cuts 70% of staff following Phase III trial failure

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

QL-325 by QLSF Biotherapeutics for Acute Myelocytic Leu...

Nov 4, 2023

Opinion: The airline industry needs some disaster management lessons. Health care can help

Opinion: The airline industry needs some disaster manag...

Aug 1, 2023

STAT+: Pharmalittle: Biden administration proposes yearly audit for costliest Medicaid drugs; few at high risk of HIV take prevention pills

STAT+: Pharmalittle: Biden administration proposes year...

May 25, 2023